GlassScriptPhysician profile
Caitlin M Geary
NPI 1407355969
$4,583.89
in general payments reported to CMS, 2019-2025
35 companies · $834 in 2025
The $834 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,122 · 2022: $1,174 · 2023: $1,173 · 2024: $281 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,277.91 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $1,149.79 | 2021-2023 | Afrezza |
| Novo Nordisk INC | $539.62 | 2021-2025 | Rybelsus, Ozempic |
| Dexcom, INC. | $272.37 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $263.19 | 2021-2023 | Mounjaro, Jardiance, Humulin |
| Corcept Therapeutics | $185.38 | 2021-2025 | Korlym |
| Tandem Diabetes Care, INC. | $177.61 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $170.58 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amgen INC. | $169.60 | 2022-2025 | Repatha, Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $162.81 | 2022-2025 | |
| Insulet Corporation | $157.98 | 2022-2023 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.69 | 2021-2025 | Jardiance |
| Abbvie INC. | $129.22 | 2021-2024 | |
| Xeris Pharmaceuticals, INC. | $126.55 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Novartis Pharmaceuticals Corporation | $118.79 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $115.28 | 2021-2025 | Unithroid |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $85.24 | 2022-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $73.09 | 2022-2025 | |
| Pfizer INC. | $63.98 | 2021-2022 | |
| Amarin Pharma, INC. | $51.08 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $50.97 | 2021-2025 | |
| Antares Pharma, INC. | $41.22 | 2022-2025 | Xyosted |
| Cequr Corporation | $37.75 | 2023-2025 | Cequr Simplicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.09 | 2022-2023 | Cycloset |
| Astrazeneca Pharmaceuticals LP | $35.36 | 2021 | |
| Alexion Pharmaceuticals, INC. | $34.33 | 2025 | Strensiq |
| Neurocrine Biosciences, INC. | $29.61 | 2025 | |
| Recordati_rare_diseases_inc. | $27.46 | 2025 | Isturisa |
| Esperion Therapeutics, INC. | $24.44 | 2023 | Nexletol |
| Ascendis Pharma Endocrinology INC | $22.57 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $20.11 | 2025 | Twiist |
| Ibsa Pharma INC. | $19.64 | 2023 | Tirosint, Licart |
| Amryt Pharma Holdings LTD | $17.17 | 2023 | Mycapssa |
| Medtronic, INC. | $16.87 | 2022 | |
| Lifescan, INC. | $13.32 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Geary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.